Cryo-Cell International Income Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	31.28	31.57	31.99	31.34	30.34	28.88
Revenue Growth (YoY)	-2.56%	-1.31%	2.05%	3.32%	5.03%	-7.26%
Cost of Revenue	7.05	7.38	7.95	8.39	8.79	8.99
Gross Profit	24.23	24.19	24.04	22.95	21.54	19.9
Selling, General & Admin	18.59	18.22	18.52	17.17	15.58	14.61
Depreciation & Amortization Expenses	0.74	0.75	0.48	1.12	1.12	0.83
Research & Development	0.34	0.38	1.24	1.17	0.38	0.05
Other Operating Expenses	-	4.36	0.31	15.79	0.44	0.38
Total Operating Expenses	19.68	23.71	20.56	35.26	17.52	15.88
Operating Income	0.19	0.48	3.48	-12.3	4.02	4.02
Interest Expense	-2.03	-2.07	-1.86	-1.24	-1.52	-1.38
Other Non-Operating Income (Expense)	-0.96	-0.75	1.19	0.18	0.82	-0.03
Total Non-Operating Income (Expense)	-2.99	-2.82	-0.68	-1.06	-0.71	-1.41
Pretax Income	-2.8	-2.34	2.8	-13.36	3.32	2.61
Provision for Income Taxes	-0.14	0.09	2.4	-3.84	0.55	0.53
Net Income	-2.67	-2.43	0.4	-9.52	2.77	2.08
Net Income to Common	-2.67	-2.43	0.4	-9.52	2.77	2.08
Net Income Growth	-	-	-	-	33.02%	-42.52%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	-1.77%	-1.75%	-1.54%	-1.69%	1.46%	2.72%
EPS (Basic)	-0.33	-0.30	0.05	-1.14	0.33	0.26
EPS (Diluted)	-0.33	-0.30	0.05	-1.14	0.33	0.25
EPS Growth	-	-	-	-	32.00%	-44.44%
Shares Outstanding	8.06	8.06	8.08	8.29	8.5	8.55
Free Cash Flow	4.94	5.25	3.61	2.08	-3.6	6.09
Free Cash Flow Growth	-5.85%	45.49%	73.36%	-	-	-27.19%
Free Cash Flow Per Share	0.61	0.65	0.44	0.25	-0.42	0.73
Dividends Per Share	0.150	0.400	0.250	-	-	-
Dividend Growth	-62.50%	60.00%	-	-	-	-
Gross Margin	77.47%	76.63%	75.15%	73.23%	71.02%	68.88%
Operating Margin	0.61%	1.53%	10.88%	-39.26%	13.27%	13.91%
Profit Margin	-8.52%	-7.70%	1.26%	-30.38%	9.14%	7.21%
FCF Margin	15.80%	16.63%	11.28%	6.64%	-11.85%	21.09%
EBITDA	1.17	1.47	4.17	-10.9	5.52	5.06
EBITDA Margin	3.75%	4.65%	13.05%	-34.79%	18.21%	17.51%
EBIT	0.19	0.48	3.48	-12.3	4.02	4.02
EBIT Margin	0.61%	1.53%	10.88%	-39.26%	13.27%	13.91%
Effective Tax Rate	4.84%	-3.95%	85.66%	28.75%	16.50%	20.21%

Updated Apr 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q